300 NORTH CAPITAL, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 204 filers reported holding SEATTLE GENETICS INC in Q1 2015. The put-call ratio across all filers is 2.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
300 NORTH CAPITAL, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q1 2015$789,000
-6.2%
22,299
-14.8%
0.17%
-10.3%
Q4 2014$841,000
-13.5%
26,180
+0.1%
0.19%
-24.8%
Q3 2014$972,000
-53.0%
26,153
-51.6%
0.26%
-49.3%
Q2 2014$2,068,000
-12.4%
54,053
+4.4%
0.51%
-16.8%
Q1 2014$2,360,000
+21.8%
51,763
+6.6%
0.61%
+14.0%
Q4 2013$1,938,000
-12.4%
48,573
-3.8%
0.54%
+4.1%
Q3 2013$2,213,000
+163.5%
50,502
+89.1%
0.52%
+57.8%
Q2 2013$840,00026,7000.33%
Other shareholders
SEATTLE GENETICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,876,712$1,020,792,0008.49%
Lagoda Investment Management, L.P. 617,204$21,818,0005.84%
Redmile Group, LLC 1,052,666$37,212,0003.34%
Opus Point Partners Management, LLC 111,050$3,926,0003.29%
SOUND ENERGY PARTNERS, INC. 10,000$354,0002.33%
EMORY UNIVERSITY 29,535$1,044,0001.97%
SECTORAL ASSET MANAGEMENT INC 1,260,275$44,551,0001.69%
CORRADO ADVISORS, LLC 104,175$3,683,0001.59%
WASATCH ADVISORS LP 3,462,749$122,408,0001.27%
Baillie Gifford 15,253,520$539,213,0001.02%
View complete list of SEATTLE GENETICS INC shareholders